Effect of CHEST PAIN Center on the Treatment of Patients with ACUTE ST-Segment Elevation Myocardial Infarction in Tianjin, China
Author(s)
ABSTRACT WITHDRAWN
OBJECTIVES The acute ST-segment elevation myocardial infarction (STEMI) has severe burden of disease and economic burden in China. This study aims to evaluate the effect of chest pain center (CPC) on the treatment of patients with acute STEMI in Tianjin, in order to provide the real-world evidence to spread the mode of chest pain center in China. METHODS The retrospective study was processed using de-identified dataset derived from China Cardiovascular Association. The dataset covered diagnosed acute STEMI patients of 33 hospitals in Tianjin between October 2014 and February 2019, and were divided into CPC group and Non-CPC group. The Wilcoxon rank-sum test was used to assess the significant difference of outcomes between groups. In addition, the individual interviews were conducted with clinicians to testify the confidence of quantitative findings. RESULTS Of the 7896 patients who diagnosed acute STEMI, 6981 were divided into CPC group and 915 were divided into Non-CPC group. The Wilcoxon rank-sum test showed that the average time from first medical contact to ECG [(4.36±19.90)min vs. (5.58±29.69)min, P<0.001], the average time from first medical contact to balloon [(90.36±54.43)min vs. (94.87±61.40)min, P<0.001] and the average time from door to balloon [(71.40±30.59)min vs. (88.70±51.27)min, P<0.001] were significantly shorter in the CPC group than those in the Non-CPC group. The results of 6 individual interviews engaged with corresponding stakeholders were coincidences as quantitative findings. CONCLUSIONS Based on the both quantitative and qualitative results, through the certification and standardized operation of CPC, the time of treatment for acute STEMI patients can be significantly shortened and the mode of CPC should be popularized in China.
Conference/Value in Health Info
2020-09, ISPOR Asia Pacific 2020, Seoul, South Korea
Value in Health Regional, Volume 22S (September 2020)
Code
PCV30
Topic
Clinical Outcomes, Real World Data & Information Systems
Topic Subcategory
Comparative Effectiveness or Efficacy, Data Protection, Integrity, & Quality Assurance, Health & Insurance Records Systems, Reproducibility & Replicability
Disease
Cardiovascular Disorders